|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Non-cash interest expense | |||||
| Net amortization of premium on marketable securities | |||||
| Depreciation and amortization expense | |||||
| Write-off of deferred offering costs | |||||
| Change in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred collaboration revenue | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Acquisitions of fixed assets | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Issuance costs | |||||
| Proceeds from exercise of stock options | |||||
| Tax withholding payments for net share-settled equity awards | |||||
| Proceeds from employee stock purchase plan | |||||
| Debt end of term charge paid in cash | |||||
| Net cash provided by (used in) financing activities | |||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | |||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||
| Cash paid during the period for interest | |||||
| Common stock issued in connection with Helio Vision, Inc. acquisition milestone | |||||
| Total common stock issued in connection with Helio Vision, Inc. acquisition milestone | |||||
Loading...